Tianjin Development's subsidiary invests RMB 85 million to subscribe to wealth management products

AASTOCKS
2025.12.29 01:39

TIANJIN DEV (00882.HK) announced that last Wednesday (24th), its indirectly non-wholly-owned subsidiary Lishengpharma entered into the twelfth wealth management agreement with INDUSTRIAL BANK, subscribing to another structured deposit with a principal amount of RMB 85 million. The investment period is 182 days, with an expected annualized yield of 1.2% to 1.6%